Gender Inequalities in Acute Myeloid Leukemia Poster Presentations at the American Society of Hematology: A Five-Year Trend

• Published in: Blood 2021-11, Vol.138 (Supplement 1), p.4035-4035
• Main Authors: Sumbly, Vikram, Compas, Frantzcess, Grewal, Harneet Kaur, Shaukat, Tanveer, Iqbal, Saba, Ariyaratnam, Jonathan, Alshamam, Mohsen, Keever, Katherine, Anwer, Faiz, Rizzo, Vincent
• Format: Article
• Language: English
• ISSN: 0006-4971; 1528-0020
• DOI: 10.1182/blood-2021-147031

Introduction: Although gender disparities are continually improving within the medical field, these issues persist in academia and are evident in research authorship. The purpose of this study was to monitor the trend of such phenomena at the American Society of Hematology (ASH) Annual Meeting from 2016-2020. Methods: We extracted data from acute myeloid leukemia (AML) poster presentations that were presented at the American Society of Hematology (ASH) Annual Meeting from 2016-2020. All poster presentations (n=1599) that fell under the “Acute myeloid leukemia: Clinical studies”,“Acute myeloid leukemia: Commercially available therapy, excluding transplantation”, “Acute myeloid leukemia: Novel therapy excluding transplantation” and “Acute myeloid leukemia: Biology, cytogenetic and molecular markers in diagnosis and prognosis” subgroups were included in the study. There was a particular focus on the number of authors per poster presentation, gender of the first author, gender of the last author and geographical location of the first and last authors. The Google search engine was used to access to authors' biographical data and confirm their gender. T-tests and chi-square tests were used to better understand the gender differences. Results: The average number of authors per poster presentation was 12.5. Of the 1599 posters reviewed, men represented the majority of all first authors (917/1599 (57%) vs 682/1599 (43%); p=0.014) (Figure 1). Men were more likely to be final authors compared to women (1186/1599 (74%) vs 413/1599 (26%); p